SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MELA Sciences
An SI Board Since May 2011
Posts SubjectMarks Bans Symbol
103 4 0 MELA
Emcee:  Savant Type:  Moderated
MELA Sciences is a medical technology company focused on developing MelaFind, a
non-invasive and objective multi-spectral computer vision system intended to aid
in the detection of early melanoma. MELA Sciences designed MelaFind to assist in
the evaluation of clinically atypical pigmented skin lesions, when a
dermatologist chooses to obtain additional information before making a final
decision to biopsy to rule out melanoma. MelaFind acquires and displays
multi-spectral (from blue to near infrared) and reconstructed RGB digital images
of pigmented skin lesions and uses automatic image analysis and statistical
pattern recognition to help identify lesions to be considered for biopsy to rule
out melanoma, the deadliest form of skin cancer. Although no cure is currently
available for advanced-stage melanoma, melanoma is virtually 100% curable if
caught early.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
103SSKN... QTRLY REPORT STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q1 2Savant-5/12/2022
102SSKN, was MELA... Equities research analysts predict that STRATA Skin Sciences,Savant-1/16/2021
101seekingalpha.comSavant-8/6/2019
100SSKN...jump up on volume, then retraced The company's product portfolio incSavant-3/11/2016
99Changed to SSKN symbol Strata Skin Sciences...was MELA On January 5, MELA ScienSavant-1/6/2016
98Mela Sciences Inc (MELA) Technicals are showing great signs of upside potentialsfnsie-1/6/2016
97MELA: MELA Sciences will be STRATA Skin Sciences on January 5 10:24 am, Tue,Savant-12/22/2015
96Mela Sciences up big premarket on reimbursement codes for MelaFind system• 8:11 Savant-3/11/2015
95Jan 13... HC Wainwright MELA pick, target $4.50.. Touched 4.05$ today, close tSavant-3/11/2015
94MELA Sciences Names Michael R. Stewart Its Next President and CEO IRVINGSavant-11/19/2014
93 Outcomes Study Reports Use of MelaFind Reduced Benign Biopsies by 61Savant-10/21/2014
92 Mela Sciences Holders to Offer Up to 21.6M Common ShrsSavant-10/21/2014
91MELA Sciences Collaborates With Columbia University Imaging Experts ColuSavant-8/27/2014
90MELA Sciences Reports Second Quarter 2014 Financial Results and Provides a BusinSavant-8/13/2014
89MELA Sciences to Host Analyst Meeting and Webcast on Wednesday, August 13 in NewSavant-8/7/2014
88MELA Sciences Regains Compliance With NASDAQ Listing Requirements IRVINGSavant-7/30/2014
87MELA Sciences Reports the Closing of Its Private Placement IRVINGTON, N.Savant-7/30/2014
86MELA Sciences Announces New Study Results Demonstrating Improved DiagnostSavant-7/24/2014
85MELA Sciences Announces $27.3 Million At The Market Private Placement of Savant-7/22/2014
84MELA Sciences Begins Insurance Reimbursement Process With Application for New CPSavant-7/21/2014
83MELA rev split 1 for 10 8K... Material Modification to Rights of SecuriSavant-7/21/2014
82MELA Sciences Initiates First Study to Investigate Real-World Clinical ImSavant-6/3/2014
81 MELA Sciences Predictive Probability Study Supports Increased DiagnoSavant-5/8/2014
80 MELA Sciences Secures Final Investigative Site and Enrolls 100+ PatiSavant-4/30/2014
79 edical Diagnostic Developer MELA Sciences Appoints Senior HealthcareSavant-4/10/2014
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):